Vigil Neuroscience Inc. (VIGL) NASDAQ
$3.55 0.06 (1.72%)
Market Cap: $130.98M
As of 05/16/24 03:59 PM EDT. Market closed.
Vigil Neuroscience Inc. (VIGL)
NASDAQ
$3.55
0.06 (1.72%)
Market Cap: $130.98M
As of 05/16/24 03:59 PM EDT. Market closed.
Add to Portfolio
vigil neuroscience is the world’s first microglia-focused therapeutics company. our purpose is clear: to treat rare and common neurodegenerative diseases by restoring the vigilance of the microglia, the sentinel cells of the brain’s immune system. we are utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
50
URL
Address
.
PRICE CHART FOR VIGIL NEUROSCIENCE INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$3.57
Previous Close
$3.49
Days Range
$3.28 - $3.70
52 week range
$2.50 - $11.11
Volume
32,182
Avg. Volume (30 days)
114,660
Market Cap
$130.98M
Dividend Yield
-
P/E
-
Shares Outstanding
37,584,312
Open
$3.57
Previous Close
$3.49
Days Range
$3.28 - $3.70
52 week range
$2.50 - $11.11
Volume
32,182
Avg. Volume (30 days)
114,660
Market Cap
$130.98M
Dividend Yield
-
P/E
-
Shares Outstanding
37,584,312
FINANCIAL STATEMENTS FOR VIGIL NEUROSCIENCE INC
LOADING...
INSIDER TRANSACTIONS FOR VIGIL NEUROSCIENCE INC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Magovcevic-Liebisch Ivana | President and CEO | Nov 20, 2023 | Buy | $3.75 | 4,000 | 15,000 | 207,687 | Nov 20, 2023, 06:34 PM |
Papapetropoulos Spyros | Chief Medical Officer | Nov 18, 2022 | Option Exercise | $1.89 | 300 | 567 | 4,300 | Nov 22, 2022, 09:45 PM |
Papapetropoulos Spyros | Chief Medical Officer | Nov 18, 2022 | Sale | $14.00 | 300 | 4,200 | 4,000 | Nov 22, 2022, 09:45 PM |
Thorp Clay | Director | May 17, 2022 | Buy | $2.97 | 14,893 | 44,189 | 1,556,030 | May 17, 2022, 09:06 PM |
Thorp Clay | Director | May 16, 2022 | Buy | $2.76 | 21,802 | 60,221 | 1,541,137 | May 17, 2022, 09:06 PM |
Thackaberry Evan | SVP, Head of Early Development | May 05, 2022 | Buy | $4.00 | 1,500 | 6,000 | 1,500 | May 06, 2022, 07:00 AM |
Verni Christopher | General Counsel | May 03, 2022 | Buy | $3.77 | 4,000 | 15,074 | 4,000 | May 04, 2022, 07:00 AM |
Magovcevic-Liebisch Ivana | President and CEO | May 02, 2022 | Buy | $3.61 | 4,000 | 14,439 | 202,687 | May 04, 2022, 07:00 AM |
Magovcevic-Liebisch Ivana | President and CEO | May 03, 2022 | Buy | $3.94 | 1,000 | 3,940 | 203,687 | May 04, 2022, 07:00 AM |
Ziolkowski Jennifer Lynn | Chief Financial Officer | May 03, 2022 | Buy | $3.77 | 4,000 | 15,098 | 4,000 | May 04, 2022, 07:00 AM |
Papapetropoulos Spyros | Chief Medical Officer | May 03, 2022 | Buy | $3.40 | 4,000 | 13,591 | 4,000 | May 04, 2022, 07:00 AM |
Thorp Clay | Director | Mar 28, 2022 | Buy | $7.20 | 3,000 | 21,604 | 3,000 | Mar 28, 2022, 04:44 PM |
Thorp Clay | Director | Jan 11, 2022 | Buy | $14.00 | 265,000 | 3,710,000 | 1,519,335 | Jan 11, 2022, 09:20 PM |
Vida Ventures GP III, L.L.C. | 10% Owner | Jan 11, 2022 | Buy | $14.00 | 3,852 | 53,928 | 11,536 | Jan 11, 2022, 09:18 PM |
Vida Ventures GP III, L.L.C. | 10% Owner | Jan 11, 2022 | Buy | $14.00 | 1,671,148 | 23,396,072 | 5,004,393 | Jan 11, 2022, 09:18 PM |
Atlas Venture Fund XII, L.P. | 10% Owner | Jan 11, 2022 | Buy | $14.00 | 535,000 | 7,490,000 | 4,808,896 | Jan 11, 2022, 09:15 PM |
Booth Bruce | Director | Jan 11, 2022 | Buy | $14.00 | 535,000 | 7,490,000 | 4,808,896 | Jan 11, 2022, 09:11 PM |
Vitorovic Stefan | Director | Jan 11, 2022 | Buy | $14.00 | 3,852 | 53,928 | 11,536 | Jan 11, 2022, 09:11 PM |
Vitorovic Stefan | Director | Jan 11, 2022 | Buy | $14.00 | 1,671,148 | 23,396,072 | 5,004,393 | Jan 11, 2022, 09:11 PM |
Northpond Ventures GP, LLC | 10% Owner | Jan 11, 2022 | Buy | $14.00 | 355,000 | 4,970,000 | 1,382,978 | Jan 11, 2022, 08:18 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Load More Insider Transactions
FUNDS WITH A POSITION IN VIGIL NEUROSCIENCE INC
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 980,311 | 0.06% | -16.46% | Other |
BLACKROCK INC. | 877,032 | 0.00007% | -4.58% | Other |
ORBIMED ADVISORS LLC | 448,891 | 0.03% | No change | Other |
GEODE CAPITAL MANAGEMENT, LLC | 334,242 | 0.00011% | 5.93% | Other |
RENAISSANCE TECHNOLOGIES LLC | 59,964 | 0.00032% | New | Other |
CHANGE IN SHARES OUTSTANDING FOR VIGIL NEUROSCIENCE INC
STOCK BUYBACKS FOR VIGIL NEUROSCIENCE INC
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0.06%
1Q
06/30/2023
0.46%
2Q
03/31/2023
0.75%
3Q
12/31/2022
22.56%
4Q
09/30/2022
16.61%
5Q
06/30/2022
37.95%
6Q
03/31/2022
45.66%
7Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR VIGIL NEUROSCIENCE INC
LOADING...